- Q1 2024 Emergent BioSolutions Inc Earnings Call TranscriptMay 01, 2024Earnings
- Q4 2023 Emergent BioSolutions Inc Earnings Call TranscriptMar 06, 2024€3.04 (-3.55%)Earnings
- Emergent BioSolutions Inc at JPMorgan Healthcare Conference TranscriptJan 11, 2024
- Q3 2023 Emergent BioSolutions Inc Earnings Call TranscriptNov 08, 2023€2.22 (+2.58%)Earnings
- Q2 2023 Emergent BioSolutions Inc Earnings Call TranscriptAug 08, 2023€6.66 (+0.60%)Earnings
- Q1 2023 Emergent BioSolutions Inc Earnings Call TranscriptMay 09, 2023€8.26 (+2.48%)Earnings
- Q4 2022 Emergent BioSolutions Inc Earnings Call TranscriptFeb 27, 2023€12.94 (-3.53%)Earnings
- Q3 2022 Emergent BioSolutions Inc Earnings Call TranscriptNov 08, 2022€20.18 (+0.96%)Earnings
- Q2 2022 Emergent BioSolutions Inc Earnings Call TranscriptAug 01, 2022€33.67 (-4.70%)Earnings
- Emergent BioSolutions Inc at Goldman Sachs Leveraged Finance and Credit Conference TranscriptMay 12, 2022
- Emergent BioSolutions Inc at Bank of America Healthcare Conference TranscriptMay 10, 2022
- Q1 2022 Emergent BioSolutions Inc Earnings Call TranscriptApr 28, 2022€34.68 (-0.43%)Earnings
- Emergent BioSolutions Inc at KeyBanc Capital Markets Life Sciences & MedTech Forum (Virtual) TranscriptMar 22, 2022
- Q4 2021 Emergent BioSolutions Inc Earnings Call TranscriptFeb 24, 2022€36.49 (-3.85%)Earnings
- Emergent BioSolutions Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 10, 2022
- Q3 2021 Emergent BioSolutions Inc Earnings Call TranscriptNov 04, 2021€45.25 (+3.38%)Earnings
- Emergent BioSolutions Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 13, 2021
- Q2 2021 Emergent BioSolutions Inc Earnings Call TranscriptJul 29, 2021€54.82 (+4.30%)Earnings
- Emergent BioSolutions Inc Annual Shareholders Meeting TranscriptMay 20, 2021
- Q1 2021 Emergent BioSolutions Inc Earnings Call TranscriptApr 29, 2021€50.48 (-4.07%)Earnings
- Emergent BioSolutions Inc at Cowen Healthcare Conference (Virtual) TranscriptMar 01, 2021
- Q4 2020 Emergent BioSolutions Inc Earnings Call TranscriptFeb 18, 2021€101Earnings
- Emergent BioSolutions Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2021
- Q3 2020 Emergent BioSolutions Inc Earnings Call TranscriptNov 05, 2020€84 (+5.66%)Earnings
- Emergent BioSolutions Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 14, 2020
- Q2 2020 Emergent BioSolutions Inc Earnings Call TranscriptJul 30, 2020€80 (+2.56%)Earnings
- Emergent BioSolutions Inc Annual Shareholders Meeting TranscriptMay 21, 2020
- Emergent BioSolutions Inc at Bank of America Merrill Lynch Healthcare Conference (Virtual) TranscriptMay 12, 2020
- Q1 2020 Emergent BioSolutions Inc Earnings Call TranscriptApr 30, 2020€68.5 (+0.74%)Earnings
- Q4 2019 Emergent BioSolutions Inc Earnings Call TranscriptFeb 20, 2020€59.5 (+0.85%)Earnings
- Emergent BioSolutions Inc at JPMorgan Healthcare Conference TranscriptJan 14, 2020
- Emergent BioSolutions Inc Analyst and Investor Day TranscriptNov 21, 2019
- Q3 2019 Emergent BioSolutions Inc Earnings Call TranscriptNov 06, 2019€52 (+2.97%)Earnings
- Q2 2019 Emergent BioSolutions Inc Earnings Call TranscriptAug 01, 2019€39.65 (-0.92%)Earnings
- Emergent BioSolutions Inc Annual Shareholders Meeting TranscriptMay 23, 2019
- Q1 2019 Emergent BioSolutions Inc Earnings Call TranscriptMay 02, 2019€46.51 (-2.15%)Earnings
- Q4 2018 Emergent BioSolutions Inc Earnings Call TranscriptFeb 21, 2019€57.45 (-0.95%)Earnings
Q1 2020 Emergent BioSolutions Inc Earnings Call Transcript
Ladies and gentlemen, thank you for standing by, and welcome to the Q1 2020 Emergent BioSolutions Earnings Conference Call. (Operator Instructions) Please be advised that today's conference call may be recorded.
I would now like to hand the conference over to the company for opening remarks.
Thank you, Valerie, and good afternoon, everyone. My name is Bob Burrows. I'm Vice President of Investor Relations for Emergent, and thank you for joining us today as we discuss the operational and financial results for the first quarter of 2020. As is customary, today's call is open to all participants, and in addition, the call is being recorded and is copyrighted by Emergent BioSolutions.
The agenda for today's call will be a slight modification to our normal approach. Participating on the call with prepared comments will be Bob Kramer, President and Chief Executive Officer, and Rich Lindahl, Chief Financial Officer. However, in acknowledgement to recent announcements from the company, in between
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)